ESRX NASDAQ
Express Scripts Holding Company
1W: -6.0%
1M: -3.1%
3M: -2.4%
1Y: +24.8%
3Y: +5.9%
5Y: +36.0%
$92.33
Last traded 2018-12-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range101.73-66.93
Volume0
Avg Volume4,318,027
Beta0.90
Dividend—
Analyst Ratings
No analyst coverage
About Express Scripts Holding Company
Express Scripts, established in 1986, functions as a pharmacy benefit management (PBM) enterprise. It offers a comprehensive array of integrated services, including the processing of prescription claims, home delivery of medications, strategic management of drug formularies, specialized pharmaceutical support via its Accredo division, and insightful analytics derived from drug usage data. The company became a subsidiary of Cigna in December 2018, following its acquisition for $54 billion.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Stettin Glen D. | D-Return | 31,678 | $69.57 | 2018-12-20 |
| Stettin Glen D. | D-Return | 30,715 | $67.62 | 2018-12-20 |
| Stettin Glen D. | D-Return | 1,501 | — | 2018-12-20 |
| Stettin Glen D. | D-Return | 27,234 | $58.17 | 2018-12-20 |
| Stettin Glen D. | D-Return | 23,996 | $77.15 | 2018-12-20 |